Systemic lupus erythematosus (SLE) is a prototypic chronic, multiorgan autoimmune disease characterized by immune complex deposition and vasculopathy, and, therefore, can affect any organ and tissue of the human body.
13 days ago
Specific differences in cancer risk have been observed between systemic lupus erythematosus patients and the general population. Although meta-analyses have estimated cancer incidence in systemic lupus erythematosus patients, results have been inconclusive.
Cannabidiol is a non-psychotropic component of
cannabis sativa. Known to induce an immunomodulatory effect,
cannabidiol’s therapeutic properties have been explored in a
number of autoimmune diseases.
Specific differences in cancer risk have been observed between systemic lupus erythematosus (SLE) patients and the general population. In past decades, various studies have investigated
the relationship between SLE and malignancy
Systemic lupus erythematosus (SLE) is primarily a
relapsing-remitting (RR) disease with unpredictable flares interspersed with periods of clinical quiescence of varying duration. Initial studies on the patterns of disease activity over time described
three different subgroups of patients: long quiescent, RR and chronically active after 4.5 years of follow up
Bioinformatics analysis of differentially expressed gene profiles associated with systemic lupus erythematosus
No association between the risk of breast cancer and systemic lupus
erythematosus: evidence from a meta-analysis
Studies from other countries have reported an incidence of remission and LLDAS more comparable to our’s than to Zen et al's suggesting than in disadvantaged SLE populations, LLDAS may be an alternative, yet not the ideal, treatment target.
Our knowledge of the importance of vitamin D has grown rapidly in recent years, as its influences on different organ systems of the body have been studied...